Stockreport

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

Vivani Medical, Inc.  (VANI) 
PDF Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of 2026 and parallel investments in studies to en [Read more]